Masahiko Nishiyama, MD, PhD
Department of Molecular Pharmacology & Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Masahiko Nishiyama has currently served as Executive Advisor to the President, Gunma University and Professor of Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine where he teaches and does research on the Translational Cancer Research since 2012. He received his M.D. and Ph.D. from Hiroshima University in 1987 and began work as Research Associate at the Department of Surgery, Research Institute for Radiation Biology and Medicine, Hiroshima University from 1987-1994. After he worked at the Molecular Pharmacology, Insitut de Cancerologie et d’immunogenetique, Vileljuif, France from 1988-1990 and was Lecturer at the Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University from 1994-1996, he held appointments as Professor working in various disease areas at Biochemistry & Biophysics, and Translational Cancer Research, Research Institute for Radiation Biology and Medicine, Hiroshima University from 1996-2007. He joined the Translational Research Center, Saitama Medical University International Medical Center in 2007 and was subsequently appointed as Professor/Director at the Research Institute for Development of Therapeutics, and the Division of Disease Control in the Research Center for Genome Medicine, Saitama Medical University from 2007-2012. Concurrently, he served as Chairman of Board of Directors of Japanese Society of Clinical Oncology from 2011-2015, Chairperson of Federation of Asian Clinical Oncology from 2012-2015, and CEO from 2016 up to the present time.